Recent Research Funding

We receive funding from a variety of sources that recognize the value of our high-impact research.

  • Regulation of mRNA decay in retinal development and maintenance.Xiuqian Mu (Principal Investigator). National Eye Institute. $2,024,085. 4/1/2020-3/1/2024.
  • ER stress and diabetic retinopathy.Sarah Zhang (Principal Investigator). NIH, NEI. 9/1/2010-2/1/2024.
  • Molecular Mechanisms of Severe Diabetic Retinopathy.Sarah Zhang (Principal Investigator). NIH. 2/1/2020-1/1/2024.
  • Investigating the Action and Physiological Role of Slc4a11 in the Cornea.Michael Duffey (Co-Investigator), Sangita Patel (Co-Investigator). NIH National Eye Institute. $1,972,804. 2/1/2018-1/1/2023.
  • Investigating the Action and Physiological Role of Slc4a11 in the Cornea (NIH R01 EY028580).Michael Duffey (Co-Investigator), Mark Parker (Principal Investigator), Sangita Patel (Co-Investigator). NIH. 1/1/2018-1/1/2023.
  • NIH K08 (EY029007) Sex disparity and estradiol in Fuchs‘ endothelial corneal dystrophy.Sangita Patel (Principal Investigator). NIH. $854,900. 1/1/2018-1/1/2023.
  • Development and characterization of mouse models of RP59 DHDDS deficiency.Steven Fliesler (Co-Principal Investigator). National Eye Institute/NIH. $2,208,923. 9/1/2018-6/1/2022.
  • Regulatory mechanisms for retinal ganglion cell genesis.Xiuqian Mu (Principal Investigator). National Institutes of Health. $1,960,167. 9/1/2017-5/1/2022.
  • A Ribozyme Rescue Strategy for Autosomal Dominant Retinitis Pigmentosa.John Sullivan (Co-Investigator). National Eye Institute. $975,000. 9/1/2003-9/1/2021.
  • Targeting Neuroinflammation for RGC Protection in Glaucoma.Sarah Zhang (Principal Investigator). BrightFocus Foundation. 7/1/2019-6/1/2021.
  • Novartis RAINBOW Trial.James Reynolds (Contributor). Novartis. 1/1/2015-1/1/2021.
  • ER stress and diabetic retinopathy (Admin Supplements).Sarah Zhang (Principal Investigator). NIH, NEI. 9/1/2018-8/1/2020.
  • Role of iExaminer as Teaching Aid for Direct Ophthalmoscopy.Andrew Reynolds (Principal Investigator). Welch Allyn. 12/1/2017-12/1/2019.
  • Clinical Translational Science Award (CTSA).John Canty, Jr. (Co-Principal Investigator), Margarita Dubocovich (Principal Investigator), Peter Elkin (Co-Investigator), Leonard Epstein (Co-Investigator), Steven Fliesler (Co-Investigator), Gene Morse (Co-Investigator), Sanjay Sethi (Co-Investigator), Laurene Tumiel Berhalter (Co-Investigator). National Institutes of Health. $16,000,000. 1/1/2016-1/1/2019.